References
- Hickman C Lewis KS Little R Rastogi RG Yonker M Prevention for Pediatric and Adolescent Migraine Headache 2015 Nov 55 10 1371 81 10.1111/head.12699 26442833
- Bigal ME Edvinsson L Rapoport AM Lipton RB Spierings EL Diener HC Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study Lancet Neurol 2015 Nov 14 11 1091 100 10.1016/S1474-4422(15)00245-8 26432181
- Noruzzadeh R Modabbernia A Aghamollaii V Ghaffarpour M Harirchian MH Salahi S Memantine for Prophylactic Treatment of Migraine Without Aura: A Randomized Double-Blind Placebo-Controlled Study Headache 2016 Jan 56 1 95 103 10.1111/head.12732 26638119
- Peres M Goncalves A Double-Blind, Placebo Controlled, Randomized Clinical Trial Comparing Melatonin 3 mg, Amitriptyline 25 mg and Placebo for Migraine Prevention Neurology 2013 80 2013 S40.005
- Fallah R Shoroki FF Ferdosian F Safety and efficacy of melatonin in pediatric migraine prophylaxis Curr Drug Saf 2015 10 2 132 5 10.2174/1574886309666140605114614 24909684
DOI: https://doi.org/10.15844/pedneurbriefs-30-1-4 | Journal eISSN: 2166-6482
Language: English
Page range: 5 - 5
Submitted on: Jan 20, 2016
Accepted on: Jan 29, 2016
Published on: Mar 11, 2016
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
Keywords:
© 2016 William Qubty, Amy A. Gelfand, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.